We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
+28.88%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$453M
AUM Growth
-$9.38M
(-2%)
Cap. Flow
-$94.9M
Cap. Flow
% of AUM
-20.93%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
909
New
156
Increased
102
Reduced
243
Closed
406
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$44.3M |
| 2 |
Microsoft
MSFT
|
+$6.19M |
| 3 |
Accenture
ACN
|
+$5.66M |
| 4 |
Biogen
BIIB
|
+$4.48M |
| 5 |
United Airlines
UAL
|
+$3.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$11.2M |
| 2 |
ExxonMobil
XOM
|
+$4.17M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$3.6M |
| 4 |
FedEx
FDX
|
+$3.15M |
| 5 |
Baidu
BIDU
|
+$2.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.06% |
| 2 | Consumer Discretionary | 12.14% |
| 3 | Healthcare | 10.09% |
| 4 | Consumer Staples | 9.74% |
| 5 | Industrials | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZNGA
76
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $1.45M | 0.32% |
151,900
+9,800
| +7% | +$80.4K |
|
77
RingCentral
RNG
$4.77B
| $1.43M | 0.32% |
5,025
+1,232
| +32% | +$312K |
|
78
Bristol-Myers Squibb
BMY
$130B
| $1.41M | 0.31% |
+24,000
| New | +$1.44M |
|
79
Chegg
CHGG
$121M
| $1.4M | 0.31% |
20,749
-12,951
| -38% | -$692K |
|
|
STMP
80
DELISTED
Stamps.com, Inc.
STMP
| $1.4M | 0.31% |
7,600
-6,000
| -44% | -$1.03M |
|
|
FSCT
81
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $1.39M | 0.31% |
65,659
+57,100
| +667% | +$1.55M |
|
82
Gen Digital
GEN
$16.5B
| $1.39M | 0.31% |
+70,100
| New | +$1.43M |
|
|
SCHW
83
Charles Schwab
SCHW
$184B
| $1.39M | 0.31% |
41,200
-9,957
| -19% | -$357K |
|
84
iShares Semiconductor ETF
SOXX
$40.6B
| $1.38M | 0.3% |
+15,300
| New | +$1.24M |
|
85
Leidos
LDOS
$14.9B
| $1.38M | 0.3% |
14,700
-6,100
| -29% | -$601K |
|
|
SAVE
86
DELISTED
Spirit Airlines, Inc.
SAVE
| $1.36M | 0.3% |
76,527
+38,498
| +101% | +$549K |
|
87
Edwards Lifesciences
EW
$48.2B
| $1.36M | 0.3% |
19,700
+10,400
| +112% | +$739K |
|
|
LVGO
88
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $1.35M | 0.3% |
17,953
-2,900
| -14% | -$152K |
|
89
CrowdStrike
CRWD
$185B
| $1.32M | 0.29% |
52,752
-14,048
| -21% | -$282K |
|
|
CXO
90
DELISTED
CONCHO RESOURCES INC.
CXO
| $1.32M | 0.29% |
25,600
-8,536
| -25% | -$472K |
|
91
JPMorgan Chase
JPM
$950B
| $1.32M | 0.29% |
14,000
+11,300
| +419% | +$1.07M |
|
92
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
| $1.31M | 0.29% |
13,100
+8,500
| +185% | +$839K |
|
93
PVH
PVH
$4.01B
| $1.31M | 0.29% |
+27,174
| New | +$1.27M |
|
94
Arthur J. Gallagher & Co
AJG
$68.2B
| $1.29M | 0.28% |
13,200
+9,391
| +247% | +$832K |
|
95
Keysight
KEYS
$52.2B
| $1.29M | 0.28% |
12,769
-1,331
| -9% | -$131K |
|
96
Dow Inc
DOW
$20.8B
| $1.25M | 0.28% |
30,700
-21,200
| -41% | -$776K |
|
|
P
97
Everpure Inc
P
$24.3B
| $1.25M | 0.28% |
+72,000
| New | +$1.08M |
|
98
Vanguard S&P 500 ETF
VOO
$971B
| $1.25M | 0.28% |
+4,400
| New | +$1.18M |
|
99
Alcon
ALC
$33.7B
| $1.22M | 0.27% |
21,300
+7,700
| +57% | +$436K |
|
100
Archer Daniels Midland
ADM
$40.1B
| $1.21M | 0.27% |
30,218
-12,000
| -28% | -$449K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Bayesian Capital Management held 909 positions worth $453M, down 2% from $463M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bayesian Capital Management withdrew a net $94.9M in Q2 2020, closing 406 positions and reducing 243 holdings. Its most notable exit was ExxonMobil, an estimated $4.17M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $46.7M.
- Bayesian Capital Management's largest Q2 2020 buy was State Street SPDR S&P 500 ETF Trust: 151,500 shares worth $46.7M.
- Bayesian Capital Management added most to Biogen in Q2 2020, an estimated $4.48M increase.
- Bayesian Capital Management's biggest Q2 2020 reduction was Walgreens Boots Alliance, cutting an estimated $11.2M.
- Bayesian Capital Management fully exited ExxonMobil in Q2 2020, selling an estimated $4.17M.
- Bayesian Capital Management's ten largest holdings make up 21% of its $453M portfolio in Q2 2020.
- Bayesian Capital Management opened 156 new positions and closed 406 in Q2 2020.
- Bayesian Capital Management's portfolio value fell 2% quarter-over-quarter to $453M.
Based on Bayesian Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.